Abingworth as of Sept. 30, 2017
Portfolio Holdings for Abingworth
Abingworth holds 18 positions in its portfolio as reported in the September 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Crispr Therapeutics (CRSP) | 24.3 | $35M | 2.0M | 17.82 | |
| Sientra | 23.4 | $34M | 2.2M | 15.38 | |
| Paratek Pharmaceuticals | 18.1 | $26M | 1.0M | 25.10 | |
| Cymabay Therapeutics | 8.6 | $12M | 1.5M | 8.05 | |
| Chiasma | 3.7 | $5.3M | 2.1M | 2.55 | |
| Proteon Therapeutics | 2.7 | $3.9M | 2.0M | 1.95 | |
| Cascadian Therapeutics | 2.6 | $3.8M | 925k | 4.09 | |
| Immune Design | 2.5 | $3.6M | 352k | 10.35 | |
| Obseva Sa | 2.4 | $3.5M | 440k | 7.91 | |
| Cellectis S A (CLLS) | 2.0 | $2.8M | 100k | 28.42 | |
| Gtx Inc Del | 1.9 | $2.8M | 339k | 8.20 | |
| Adaptimmune Therapeutics (ADAP) | 1.4 | $2.0M | 250k | 8.18 | |
| Ultragenyx Pharmaceutical (RARE) | 1.4 | $2.0M | 38k | 53.25 | |
| Dermira | 1.3 | $1.9M | 70k | 27.00 | |
| Histogenics Corp Cmn | 1.2 | $1.8M | 889k | 1.98 | |
| Aurinia Pharmaceuticals (AUPH) | 1.1 | $1.6M | 252k | 6.27 | |
| Lombard Med (EVARF) | 1.1 | $1.5M | 3.5M | 0.44 | |
| Innocoll Hldgs | 0.2 | $322k | 537k | 0.60 |
